Capecitabine Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Indication (Colorectal Cancer, Breast Cancer, Others), By Distribution Channel (Hospitals, Clinical Laboratories, Others), Countries and Companies Report
Capecitabine is projected to register a 6.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets